Skip to main content
PLOS Pathogens logoLink to PLOS Pathogens
. 2020 Jun 4;16(6):e1008571. doi: 10.1371/journal.ppat.1008571

Cellular plasticity of pathogenic fungi during infection

Kenya E Fernandes 1, Dee A Carter 1,*
Editor: Mary Ann Jabra-Rizk2
PMCID: PMC7271979  PMID: 32497133

Introduction

A widespread trait amongst fungi is their ability to alter their morphology in response to environmental stimuli. The type and degree of alteration, which commonly includes changes in cell size and shape, can vary between strains and even between individual cells within genetically uniform populations, providing many levels of variation within species. As well as enhancing their ability to survive in different environmental niches, this variation plays an important role in the ability of human fungal pathogens to survive and cause disease in the host. Some well-known examples are the thermally dimorphic fungi, which grow as moulds at 22 °C–25 °C in the soil and covert into yeasts at 37 °C when in a mammalian host [1]. Some fungi, rather than switching between 2 distinct forms in different niches, produce a variety of forms in the host that appear to have roles in the infection process. This phenomenon has not been as extensively studied as thermal dimorphism but may be important for understanding disease progression and outcome. Here, we review selected examples of pathogenic fungi that produce distinct morphological forms when living in and on host tissues that may be linked to infection and virulence. Two genera, Candida and Malassezia, are highly adapted to the commensal lifestyle and can also become pathogenic, and 2 others, Coccidioides and Cryptococcus, have environmental components to their life cycle but show evidence of adaptation to life inside a host.

White-to-opaque and yeast-to-hyphae transitions in Candida albicans

C. albicans is a commensal of humans that colonises the mucosal surfaces of most healthy individuals but can cause life-threatening infections in immunocompromised hosts [2]. The ability to thrive in different niches within the host is crucial for survival, and C. albicans possesses an array of morphological forms that are thought to aid it in this process (Table 1; Fig 1A). During commensal growth, C. albicans exhibits a range of morphologies that appear to be suited to various host niches [3]. White, opaque, grey, and gastrointestinal-induced transition (GUT) yeast cell types have been described, and C. albicans can switch between these, enabling it to adapt rapidly to changes in its environment. White cells are smooth and round, whereas opaque cells are elongated, with more vacuoles and cell surface protuberances, and grey cells are the smallest cell type and are elongated with no protuberances [4, 5]. Opaque cells have been found to mate more efficiently than white cells and, along with grey cells, are more virulent and capable of faster proliferation on epithelial surfaces, whilst white cells are more virulent in systemic bloodstream infection models [68]. Opaque cells also possess increased resistance to macrophages and neutrophils because, unlike white cells, they do not secrete a chemoattractant, and it has been suggested that the switch to opaque cells may be a mechanism to escape the immune system [9]. GUT cells are morphologically similar to opaque cells but do not possess cell surface protuberances, are unable to mate, and seem to be specialised for commensalism in the mammalian gastrointestinal tract, displaying superior fitness to other cell types in models of this niche [10].

Table 1. The variety of morphological forms produced by pathogenic fungi that may play a role during the infection process.

Fungus Phylum Morphological Form Description
C. albicans Ascomycota hyphae long, tube-shaped filaments, multicellular
pseudohyphae elongated ellipsoids, multicellular
white cells small, round-to-oval
grey cells small, elongated ovals
opaque cells larger elongated ovals, more vacuoles, surface protuberances
GUT cells larger elongated ovals
Malassezia spp. Basidiomycota hyphae elongated, 10–25 μm in length
regular yeasts round, 8 μm in diameter
ovoid cells* ovoid, 2.5–6 μm in length
cylindrical cells* short variants 1.5–3 μm in length, long variants 6 μm in length
Coccidioides immitis and C. posadasii Ascomycota spherules spherical, 30–80 μm in diameter, containing 100–300 endospores
endospores spherical, 2–7 μm in diameter
arthroconidia* can be highly variable, including spherical, triangular, and barrel-shaped
fungal ball* spheroid mass of highly branched hyphae
Cryptococcus neoformans/gattii complex Basidiomycota regular yeasts spherical, 4–7 μm in diameter
capsule enlargement cells with large polysaccharide capsules
titan cells greater than 15 μm in diameter, thickened cell walls, larger vacuoles
micro cells smaller than 1 μm in diameter
irregular cells* elongated ellipsoids or tapered and egg-shaped
pseudohyphae* elongated ellipsoids, multicellular

*Less well-characterised morphological forms with currently unknown implications for virulence.

Abbreviations: GUT, gastrointestinal-induced transition.

Fig 1. Morphological switches and transitions during the fungal infection process.

Fig 1

(A) Yeast-to-hyphae-to-pseudohyphae transformations and switching between white, grey, opaque, and GUT yeast forms in C. albicans. (B) Reversible yeast-hyphae switching in Malassezia. (C) The spherule-endospore cycle, unique to Coccidioides infections. (D) Differentiation of regular yeast cells to produce various morphologically different forms in Cryptococcus. GUT, gastrointestional-induced transition.

With host immunosuppression, C. albicans can become an opportunistic pathogen, and this is accompanied by transitions from the unicellular yeast form to hyphal and pseudohyphal cell types [3]. Candida hyphae are long, filamentous, and multicellular [11], whilst pseudohyphae are elongated ovals that have features of both yeasts and hyphae. Depending on environmental factors, these 3 cell types can either stably proliferate to maintain their cell type or transition to the other cell types, and the ability to do so is a crucial determinant of virulence in C. albicans. Hyphal and pseudohyphal forms are invasive and are thought to have an increased ability to penetrate into host tissues and internal organs and cause damage, whilst yeast cells may aid dissemination through the bloodstream because of their small size [15, 16]. Mutants that cannot interchange between these cell types are typically defective in infection models, and isolates taken from patients with disseminated candidiasis generally contain both yeast and hyphal forms [12, 13]. Biofilms, which are complex and densely packed communities of cells with increased resistance to host defences and antifungal drugs, also typically contain all 3 cell types [14].

Yeast-to-hyphae transition and pleomorphism in Malassezia spp.

Malassezia spp. are lipid-dependent yeasts that are a major component of the normal skin mycobiome of humans and other animals, although metagenomic sequencing studies have found Malassezia DNA in various terrestrial and marine habitats, suggesting some species may inhabit a wider ecological niche than was previously assumed [1719]. Under certain conditions that induce fungal overgrowth or through host immunocompromisation, commensal Malassezia species can become opportunistic pathogens, and cause a variety of dermatological conditions. In host tissues, Malassezia can reversibly switch between yeasts of around 8 μm in diameter and hyphae or pseudohyphae of 10–25 μm in length (Table 1; Fig 1B), resulting in a characteristic “spaghetti and meatballs” appearance in scrapings from infected skin or lesions [20]. The yeast form of Malassezia has many known virulence attributes, including the ability to either up-regulate or suppress the immune response [21]. Hyphal forms are difficult to produce in vivo and are therefore less well understood, but it is thought that they can penetrate keratinised skin cells, gaining access to deeper nutrient-rich layers where they can revert to the yeast form and proliferate to replace cells being shed at the epidermal surface [15]. Beyond these commonly known forms, considerable other variations in the morphology of Malassezia have been observed, including ovoid and cylindrical cells and hyphae of varying size [22] (Table 1). To date, these morphologies have received little attention, and they may play distinct and potentially important roles in infection.

Spherule formation and hyphal polymorphism in Coccidioides immitis and C. posadasii

C. immitis and C. posadasii are soil-dwelling pathogenic fungi that cause pulmonary infection via airborne arthroconidia, which can develop into life-threatening disseminated disease in at-risk individuals [23]. Although originally thought to be an accidental pathogen and opportunist, recent studies indicate that the infection of small animals such as bats and armadillos may form part of the life cycle of Coccidioides and that it has evolved specific adaptations for host interaction [24]. Central to its pathogenicity during human infection is the production of spherules and endospores. Spherules are formed from a gradual enlargement and transformation of inhaled arthroconidia into a structure that is typically 30–80 μm in diameter and contains around 100–300 endospores [25] (Table 1; Fig 1C). Upon rupture of the spherule, the endospores are released into host tissues, where each can produce hyphal growth or develop into a new spherule, repeating the growth cycle [26]. In addition to temperature and CO2 levels, there is evidence that the transition to spherules can be stimulated by contact with neutrophils, and reversion of arthroconidia to hyphal forms has occasionally been observed in infected lung cavities with no neutrophils [23]. Other, less well-characterised morphotypes have also been observed clinically, but their role in infection is not well understood (Table 1) [27, 28].

Variation in capsule and cell size in Cryptococcus

Cryptococcus neoformans and members of the C. gattii species complex are encapsulated yeasts that cause severe respiratory and cerebral disease, primarily amongst immunocompromised individuals [29]. Although the pathogenic Cryptococcus species are considered to be environmental fungi, adaptations for survival during interactions with environmental predators such as amoebae, insects, and other short-lived organisms are thought to explain their broad host range and possession of various pathogenic traits [30]. Cryptococcus cells are typically spherical and 4–7 μm in diameter, but during human infection, the appearance of forms of varying size is common (Table 1; Fig 1D). The polysaccharide capsule possessed by Cryptococcus cells is highly dynamic and undergoes substantial enlargement during human infection [31]. Cells with enlarged capsules have been shown to be more resistant to oxidative stress, antimicrobial peptides, and phagocytosis and are generally associated with more severe pathology [32]. Both C. neoformans and members of the C. gattii complex can produce highly enlarged “titan” cells, which are greater than 15 μm in diameter and have been seen to reach up to 100 μm. Titan cells have unique characteristics, including thickened cell walls, dense capsules, large vacuoles, and polyploidy [33]. These traits appear to contribute to survival in the host, with their capsular properties increasing resistance to oxidative, nitrosative, and other stresses and their massive size preventing phagocytosis and elimination by macrophages [34]. When replicating, titan cells produce regular-sized progeny; hence, they are always part of a heterogenous mixture of cell types [35].

At the other end of the spectrum, C. neoformans can produce “micro” cells, a subpopulation of cells that are smaller than 1 μm in diameter [36]. Whilst much less research has been done on micro cells, they are a cell type that has been seen during human infection, and it is thought that they may cross biological barriers more readily because of their small size, aiding dissemination of the pathogen to other body sites [37, 38]. Micro cells are seen in different C. neoformans varieties and genotypes but have not been observed in species of the C. gattii complex [39]. Recent studies have further identified cells with unusual, irregular morphologies in some Cryptococcus strains. These can be tapered and egg-shaped or elongated and of a more pseudohyphal form. Their presence in clinical populations has been associated with increased antifungal tolerance but decreased virulence, which suggests they may promote persistence in the host [38, 39]. Like titan cells, micro and irregular cell types always appear as part of a mix of different cell types.

Conclusions

Diverse fungal morphologies are increasingly being recognised as key traits associated with virulence, aiding pathogens in various ways, including adhesion to physiological barriers, dissemination through the body, and manipulation of host immune responses [40]. Whilst some morphological forms have well-characterised implications for virulence and pathogenesis, there is still much to learn about the capacity of fungi for morphogenesis during disease progression. This knowledge may ultimately help inform disease diagnosis and prognosis, with implications for treatment strategies.

Funding Statement

KEF was supported by an Australian Research Training Program scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Sil A, Andrianopoulos A. Thermally dimorphic human fungal pathogens—polyphyletic pathogens with a convergent pathogenicity trait. Cold Spring Harb Perspect Med. 2014;5(8): a019794 10.1101/cshperspect.a019794 PubMed Central PMCID: PMC4526722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Sardi JC, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJ. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62(1): 10–24. 10.1099/jmm.0.045054-0 [DOI] [PubMed] [Google Scholar]
  • 3.Noble SM, Gianetti BA, Witchley JN. Candida albicans cell-type switching and functional plasticity in the mammalian host. Nat Rev Microbiol. 2017;15(2): 96–108. 10.1038/nrmicro.2016.157 PubMed Central PMCID: PMC5957277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Anderson J, Mihalik R, Soll DR. Ultrastructure and antigenicity of the unique cell wall pimple of the Candida opaque phenotype. J Bacteriol. 1990;172(1): 224–35. 10.1128/jb.172.1.224-235.1990 PubMed Central PMCID: PMC208422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bommanavar SB, Gugwad S, Malik N. Phenotypic switch: the enigmatic white-gray-opaque transition system of Candida albicans. J Oral Maxillofac Pathol. 2017;21(1): 82–6. 10.4103/0973-029X.203781 PubMed Central PMCID: PMC5406825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Kvaal C, Lachke SA, Srikantha T, Daniels K, McCoy J, Soll DR. Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect Immun. 1999;67(12): 6652–62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Tao L, Du H, Guan G, Dai Y, Nobile CJ, Liang W, et al. Discovery of a "white-gray-opaque" tristable phenotypic switching system in Candida albicans: roles of non-genetic diversity in host adaptation. PLoS Biol. 2014;12(4): e1001830 10.1371/journal.pbio.1001830 PubMed Central PMCID: PMC3972085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Xie J, Tao L, Nobile CJ, Tong Y, Guan G, Sun Y, et al. White-opaque switching in natural MTLa/alpha isolates of Candida albicans: evolutionary implications for roles in host adaptation, pathogenesis, and sex. PLoS Biol. 2013;11(3): e1001525 10.1371/journal.pbio.1001525 PubMed Central PMCID: PMC3608550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sasse C, Hasenberg M, Weyler M, Gunzer M, Morschhauser J. White-opaque switching of Candida albicans allows immune evasion in an environment-dependent fashion. Eukaryot Cell. 2013;12(1): 50–8. 10.1128/EC.00266-12 PubMed Central PMCID: PMC3535852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Pande K, Chen C, Noble SM. Passage through the mammalian gut triggers a phenotypic switch that promotes Candida albicans commensalism. Nat Genet. 2013;45(9): 1088–91. 10.1038/ng.2710 PubMed Central PMCID: PMC3758371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol. 2004;12(7): 317–24. 10.1016/j.tim.2004.05.008 [DOI] [PubMed] [Google Scholar]
  • 12.Di Carlo P, Di Vita G, Guadagnino G, Cocorullo G, D'Arpa F, Salamone G, et al. Surgical pathology and the diagnosis of invasive visceral yeast infection: two case reports and literature review. World J Emerg Surg. 2013;8(1): 38 10.1186/1749-7922-8-38 PubMed Central PMCID: PMC3849356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lo HJ, Kohler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR. Nonfilamentous C. albicans mutants are avirulent. Cell. 1997;90(5): 939–49. 10.1016/s0092-8674(00)80358-x [DOI] [PubMed] [Google Scholar]
  • 14.Desai JV, Mitchell AP. Candida albicans biofilm development and its genetic control. Microbiol Spectr. 2015;3(3): MB-0005–2014. 10.1128/microbiolspec.MB-0005-2014 PubMed Central PMCID: PMC4507287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Brand A. Hyphal growth in human fungal pathogens and its role in virulence. Int J Microbiol. 2012;2012: 517529 10.1155/2012/517529 PubMed Central PMCID: PMC3216317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2): 119–28. 10.4161/viru.22913 PubMed Central PMCID: PMC3654610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Theelen B, Cafarchia C, Gaitanis G, Bassukas ID, Boekhout T, Dawson TL Jr. Malassezia ecology, pathophysiology, and treatment. Med Mycol. 2018;56(suppl_1): S10–S25. 10.1093/mmy/myx134 . [DOI] [PubMed] [Google Scholar]
  • 18.Amend A. From dandruff to deep-sea vents: Malassezia-like fungi are ecologically hyper-diverse. PLoS Pathog. 2012;10(8): e1004277 10.1371/journal.ppat.1004277.g001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Richards TA, Jones MD, Leonard G, Bass D. Marine fungi: their ecology and molecular diversity. Ann Rev Mar Sci. 2012;4: 495–522. 10.1146/annurev-marine-120710-100802 [DOI] [PubMed] [Google Scholar]
  • 20.Ashbee HR. Update on the genus Malassezia. Med Mycol. 2007;45(4): 287–303. 10.1080/13693780701191373 . [DOI] [PubMed] [Google Scholar]
  • 21.Ashbee HR, Evans EG. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev. 2002;15(1): 21–57. 10.1128/CMR.15.1.21-57.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Midgley G. Morphological variation in Malassezia and its significance in pityriasis versicolor In: Bossche H, Odds FC, Kerridge D, editors. Dimorphic fungi in biology and medicine. Boston, MA: Springer; 1993. p. 267–77. [Google Scholar]
  • 23.Kirkland TN, Fierer J. Coccidioides immitis and posadasii; a review of their biology, genomics, pathogenesis, and host immunity. Virulence. 2018;9(1): 1426–35. 10.1080/21505594.2018.1509667 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Del Rocio Reyes-Montes M, Perez-Huitron MA, Ocana-Monroy JL, Frias-De-Leon MG, Martinez-Herrera E, Arenas R, et al. The habitat of Coccidioides spp. and the role of animals as reservoirs and disseminators in nature. BMC Infect Dis. 2016;16(1): 550 10.1186/s12879-016-1902-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Saubolle MA, McKellar PP, Sussland D. Epidemiologic, clinical, and diagnostic aspects of coccidioidomycosis. J Clin Microbiol. 2007;45(1): 26–30. 10.1128/JCM.02230-06 PubMed Central PMCID: PMC1828958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Nguyen C, Barker BM, Hoover S, Nix DE, Ampel NM, Frelinger JA, et al. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis. Clin Microbiol Rev. 2013;26(3): 505–25. 10.1128/CMR.00005-13 PubMed Central PMCID: PMC3719491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Munoz-Hernandez B, Martinez-Rivera MA, Palma-Cortes G, Manjarrez E. Innovation of the parasitic cycle of Coccidioides spp In: Shah MM, editor. Parasitology: InTech; 2012. [Google Scholar]
  • 28.Munoz-Hernandez B, Palma-Cortes G, Cabello-Gutierrez C, Martinez-Rivera MA. Parasitic polymorpism of Coccidioides spp. BMC Infect. 2014;14: 213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, et al. Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med. 2014;4(7): a019760 10.1101/cshperspect.a019760 PubMed Central PMCID: PMC4066639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci USA. 2001;98(26): 15245–50. 10.1073/pnas.261418798 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.O'Meara TR, Alspaugh JA. The Cryptococcus neoformans capsule: a sword and a shield. Clin Microbiol Rev. 2012;25(3): 387–408. 10.1128/CMR.00001-12 PubMed Central PMCID: PMC3416491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zaragoza O. Basic principles of the virulence of Cryptococcus. Virulence. 2019;10(1): 490–501. 10.1080/21505594.2019.1614383 PubMed Central PMCID: PMC6550552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zaragoza O, Nielsen K. Titan cells in Cryptococcus neoformans: cells with a giant impact. Curr Opin Microbiol. 2013;16(4): 409–13. 10.1016/j.mib.2013.03.006 PubMed Central PMCID: PMC3723695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Okagaki LH, Nielsen K. Titan cells confer protection from phagocytosis in Cryptococcus neoformans infections. Eukaryot Cell. 2012;11(6): 820–6. 10.1128/EC.00121-12 PubMed Central PMCID: PMC3370461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gerstein AC, Fu MS, Mukaremera L, Li Z, Ormerod KL, Fraser JA, et al. Polyploid titan cells produce haploid and aneuploid progeny to promote stress adaptation. mBio. 2015;6(5): e01340–15. 10.1128/mBio.01340-15 PubMed Central PMCID: PMC4620463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Zaragoza O. Multiple disguises for the same party: the concepts of morphogenesis and phenotypic variations in Cryptococcus neoformans. Front Microbiol. 2011;2: 181 10.3389/fmicb.2011.00181 PubMed Central PMCID: PMC3167222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Feldmesser M, Kress Y, Casadevall A. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology. 2001;147(8): 2355–65. 10.1099/00221287-147-8-2355 [DOI] [PubMed] [Google Scholar]
  • 38.Fernandes KE, Brockway A, Haverkamp M, Cuomo CA, van Ogtrop F, Perfect JR, et al. Phenotypic variability correlates with clinical outcome in Cryptococcus isolates obtained from Botswanan HIV/AIDS patients. mBio. 2018;9(5): e02016–18. 10.1128/mBio.02016-18 PubMed Central PMCID: PMC6199498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Fernandes KE, Dwyer C, Campbell LT, Carter DA. Species in the Cryptococcus gattii complex differ in capsule and cell size following growth under capsule-inducing conditions. mSphere. 2016;1(6): e00350–16. 10.1128/mSphere.00350-16 PubMed Central PMCID: PMC5196034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hewitt SK, Foster DS, Dyer PS, Avery SV. Phenotypic heterogeneity in fungi: importance and methodology. Fungal Biology Reviews. 2016;30(4): 176–84. 10.1016/j.fbr.2016.09.002 [DOI] [Google Scholar]

Articles from PLoS Pathogens are provided here courtesy of PLOS

RESOURCES